[1]杨嘉豪 徐建虎.温阳消饮法对慢性心力衰竭模型 大鼠血清 ANP、TNF-α及 IL-6水平影响[J].现代中医药,2019,(02):092-95.[doi:10.13424/j.cnki.mtcm.2019.02.028]
 Yang Jiahao Xu Jianhu.Effect of the Therapy of Warming Yang to Resolve Fluid Retention on Serum ANP, TNF -α and IL -6 Levels in Rats with Chronic Heart Failure[J].Modern Traditional Chinese Medicine,2019,(02):092-95.[doi:10.13424/j.cnki.mtcm.2019.02.028]
点击复制

温阳消饮法对慢性心力衰竭模型 大鼠血清 ANP、TNF-α及 IL-6水平影响()
分享到:

《现代中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2019年02期
页码:
092-95
栏目:
方药研究
出版日期:
2019-03-10

文章信息/Info

Title:
Effect of the Therapy of Warming Yang to Resolve Fluid Retention on Serum ANP, TNF -α and IL -6 Levels in Rats with Chronic Heart Failure
文章编号:
1672-0571(2019)02-0092-04
作者:
杨嘉豪 徐建虎
宁夏医科大学中医学院,宁夏 银川 750004
Author(s):
Yang Jiahao 1 Xu Jianhu 2
1. Postgraduate of School of Traditional Chinese Medicine, Ningxia Medical University, Yinchuan 750004; 2. School of Traditional Chinese Medicine, Ningxia Medical University, Yinchuan 750004
关键词:
温阳消饮慢性心力衰竭心房利钠肽肿瘤坏死因子 -α白介素 -6
Keywords:
warming yang to resolve fluid retention chronic cardiac failure ANP TNF - α IL -6
分类号:
R258.5
DOI:
10.13424/j.cnki.mtcm.2019.02.028
文献标志码:
A
摘要:
摘 要:目的 探索温阳消饮法对慢性心衰大鼠血清中 ANP、TNF-α及 IL-6含量水平的影响。方法 将 40 只健康雄性 SD大鼠随机分为空白组(10只)与 CHF组(30只),CHF组动物采用大鼠腹腔注射阿霉素(ADR)复 制慢性心力衰竭模型,造模结束后将 CHF组 SD大鼠随机分为模型组、温阳消饮组、美托洛尔组进行干预,四周 后观察心肌病理形态学变化,测定各组大鼠血清 ANP、TNF-α及 IL-6的浓度。结果 与空白组比较,模型组 ANP、TNF-α及 IL-6含量升高(P<0.01),与模型组比
Abstract:
To explore the effect of the therapy of warming yang to resolve fluid retention on Serum ANP, TNF - α and IL -6 Levels in Rats with chronic heart failure. Method Forty healthy male SD rats were randomly divided into blank group ( 10 rats) and CHF group ( 30 rats) . Rats in CHF group were injected intraperitoneally with adriamycin ( ADR) to replicate chronic heart failure model. After the model establishment, SD rats in CHF group were randomly divided into model group, warming yang to resolve fluid retention group and metoprolol group for intervention. After four weeks, the pathological changes of myocardium were observed and the serum ANP of rats, concentrations of TNF – alpha and IL -6 in each group were determined. Result Compared with the blank group, the contents of ANP, TNF - alpha and IL -6 in the model group increased ( P < 0. 01) . Compared with the model group, the contents of TNF - alpha and IL -6 in the warming yang to resolve fluid retention group and the metoprolol group decreased ( P < 0. 01) . Compared with the warming yang to resolve fluid retention group, the contents of IL -6 in the metoprolol group increased ( P < 0. 05) .Conclusion The therapy of warming yang to resolve fluid retention can significantly reduce the levels of TNF - alpha and IL -6 in serum of CHF rats, inhibit inflammatory reaction and improve cardiac function.

参考文献/References:

[1]敖杰男,冯慧娟,吴迪,等.炎症细胞因子在心力衰竭发病过程中的作用[J].中国病理生理杂志,2005,21(10):2062~2064.
[2]李玉玲,杨建业,唐俊明,等.阿霉素诱导大鼠心衰模型不同方案的比较[J].中国比较医学杂志,2006,16(2):93~96.
[3]张碧华,杨莉萍,唐鹏.慢性心力衰竭与中医相关病证的渊源与发展[J].中国中西医结合杂志,2018,38(5):633-635.
[4]冯亚龙,赵英永,丁凡,等.茯苓皮的化学成分及药理研究进展(1)[J].中国中药杂志,2013,38(7):1098~1102.
[5]杨娟,苑素云.浅析慢性心力衰竭的几种中医干预措施[J].中医药临床杂志,2018,30(2):216-218.
[6]江苏新医学院.中药大词典(下册)[M].上海:上海科学技术出版社,2004,2319.
[7]陈灏珠,南山,陆再英.内科学[M].北京:人民卫生出版社,2013:166.
[8]唐特,杨侃.检测血心钠肽水平对舒张性心力衰竭的诊断意义[J].内科急危重症杂志,2011,17(6):353-355.
[9]徐建虎,张琦,杨子庆,等.苓桂术甘汤合方对心衰大鼠脑钠肽?血管紧张素Ⅱ的影响[J].时珍国医国药,2016,27(6):1284~1285.
[10]曲颂扬,张艳,宫丽鸿,等.参草通脉颗粒对心衰大鼠BNP影响的实验研究[J].光明中医医,2011,26(11):2218~2219.
[11]徐梦丹.炎症与心力衰竭关系的研究进展[J].上海交通大学学报(医学版),2009,29(6):649~653.
[12] McIntyre CW, Harrison LE, Eldehni MT, et al. Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease [ J] .Clinical Journal of the American Society of Nephrology,2011,6( 1) :133 -141.
[13]刘娜娜,王茎.中医药治疗慢性心力衰竭的实验研究概况[J].中医药临床杂志,2018,30(3):400-403.
[14]吴艳君,王俊.白介素-6与心力衰竭患者心肌重构的关系研究[J].中华全科医学,2014,12(3):378-379.
[15]高玲,杨婷,王迪,等.强心活力方对慢性心力衰竭大鼠IL-6?TNF-α含量及NF-kB表达的影响[J].中华中医药杂志,2018,33(3):1070-1073.

相似文献/References:

[1]唐婉莹.益气活血利水法治疗慢性心力衰竭的疗效观察[J].现代中医药,2019,(05):058.[doi:10.13424/j.cnki.mtcm.2019.05.018]
[2]夏柔娟 蒙广阔 *.心衰合剂治疗慢性心力衰竭临床疗效观察[J].现代中医药,2018,(06):009.[doi:10.13424/j.cnki.mtcm.2018.06.004]
 Xia Roujuan Meng Guangkuo.Clinical Observation of Heart Failure Mixture in Treating Chronic Heart Failure[J].Modern Traditional Chinese Medicine,2018,(02):009.[doi:10.13424/j.cnki.mtcm.2018.06.004]
[3]田 心.从中医“圆运动”谈慢性心力衰竭诊疗指南的药物应用[J].现代中医药,2021,(02):018.[doi:10.13424/j.cnki.mtct.2021.02.004]
 TIAN Xin.Discussion on Drug Application of Chronic Heart Failure Diagnosis and Treatment Guidelines from circular movement of Chinese Medicine[J].Modern Traditional Chinese Medicine,2021,(02):018.[doi:10.13424/j.cnki.mtct.2021.02.004]
[4]张军茹.中西医视角治疗慢性心力衰竭合并高尿酸血症探析[J].现代中医药,2021,(03):001.[doi:10.13424/j.cnki.mtcm.2021.03.001]
 ZHANGJunru.TreatmentofChronicHeartFailurewithHyperuricemiafromthePerspectiveofTraditionalChineseandWesternMedicine[J].Modern Traditional Chinese Medicine,2021,(02):001.[doi:10.13424/j.cnki.mtcm.2021.03.001]
[5]杜永波** 杨建伟 王梅梅 徐新松王洪杰.基于心功能及氧化应激指标探析附萸汤 治疗慢性心力衰竭的有效性[J].现代中医药,2023,(05):074.[doi:10.13424/j.cnki.mtcm.2023.05.015]
 DU Yongbo YANG Jianwei WANG Meimei XU Xinsong WANG Hongjie.Effectiveness of Fuyu Decoction in Treating Chronic Heart Failure Based on Cardiac Function and Oxidative Stress Indicators[J].Modern Traditional Chinese Medicine,2023,(02):074.[doi:10.13424/j.cnki.mtcm.2023.05.015]
[6]王铭马立旭 王秀萍韩金荣 徐建虎.消饮化瘀方对慢性心力衰竭大鼠NTproBNP及GPR35mRNA水平的影响[J].现代中医药,2023,(05):113.[doi:10.13424/j.cnki.mtcm.2023.05.021]

备注/Memo

备注/Memo:
基金项目:宁夏高等学校科学研究项目(NGY2017119)
更新日期/Last Update: 2019-03-15